Background Image
Table of Contents Table of Contents
Previous Page  38 / 68 Next Page
Information
Show Menu
Previous Page 38 / 68 Next Page
Page Background

CARDIOVASCULAR JOURNAL OF AFRICA • Volume 30, No 3, May/June 2019

166

AFRICA

We failed to find significant differences in terms of in-hospital

mortality rate and MACE between the two groups in this study.

Two reasons may explain this. First, all of the enrolled patients

were haemodynamically and electrically stable and had patent

IRAs, which means they had a relatively low risk for mortality

and adverse events, according to the GRACE scoring system.

33

Second, only 159 patients were enrolled in the study, and the

small sample may have reduced the power to draw a significant

conclusion regarding mortality rate.

There were several potential limitations of this study. First,

it is a single-centre, retrospective study with a small sample size.

Second, most recent chest pain within 12 hours before admission

was more likely in the emergency PCI group compared with

the delayed PCI group (Table 2), which may have led to a bias

towards an emergency decision by the operator. Third, we did

not assess the TIMI thrombus grade of the IRA during the initial

angiography since TIMI thrombus grade may have contributed

to different angiography results. Finally, the blush grade was

not evaluated as a more valuable indicator for normalised

microvascular flow since this study was designed retrospectively.

Conclusion

In STEMI patients who presented late (12–72 hours) after

symptom onset and with an IRA TIMI flow of grade 2 to 3,

delayed PCI showed a higher rate of procedural success due to

a lower rate of slow flow or no re-flow, without an increase in

hospital or long-term MACE or mortality rates.

We thank Dr Qian-jin Feng for editing and revision of the manuscript. This

study was supported by the Zhongshan Major Science and Technology

Development Project (Zhong Ke Fa No. 2016B1002).

References

1.

Hong MK. Recent advances in the treatment of ST-segment elevation

myocardial infarction.

Scientifica

(Cairo)

2012;

2012

: 683683.

2.

Eagle KA, Goodman SG, Avezum A, Budaj A, Sullivan CM, López-

Sendón J,

et al

. Practice variation and missed opportunities for reperfusion

in ST-segment-elevation myocardial infarction: findings from the global

registry of acute coronary events (GRACE).

Lancet

2002;

359

: 373–377.

3.

Cohen M, Gensini GF, Maritz F, Gurfinkel EP, Huber K, Timerman

A,

et al.

Prospective evaluation of clinical outcomes after acute

ST-elevation myocardial infarction in patients who are ineligible for

reperfusion therapy: preliminary results from the TETAMI registry and

randomized trial.

Circulation

2003;

108

: III14–III21.

4.

DiPede F, Olivari Z, Schievano E, Spolaore P, Cacciavillani L, La

Vecchia L,

et al.

Impact of reperfusion strategies on in-hospital outcome

in ST-elevation myocardial infarction in a context of interhospital

network: data from the prospective VENERE registry (VENE to acute

myocardial infarction REgistry).

Ital Heart J Suppl

2005;

6

: 804–811.

5.

Fontanelli A, Bonanno C. Primary percutaneous coronary interven-

tion in ‘early’ latecomers with ST-segment elevation acute myocardial

infarction: the role of the infarct-related artery status.

J Cardiovasc Med

(Hagerstown) 2011;

12

: 13–18.

6.

Li J, Li X, Wang Q, Yu Y, Yan XF, Jiang LX. ST-segment elevation

myocardial infarction in China from 2001 to 2011 (the China PEACE-

retrospective acute myocardial infarction study): a retrospective analysis

of hospital data.

Lancet

2015;

385

: 441–451.

7.

De Luca G, Suryapranata H, Zijlstra F, van’t Hof A, Hoorntje J,

Gosselink A,

et al

. Symptom onset-to-balloon time and mortality in

patients with acute myocardial infarction treated by primary angio-

plasty.

J Am Coll Cardiol

2003;

42

: 991–997.

8.

Reimer KA, Lowe JE, Rasmussen MM, Jennings RB. The wavefront

phenomenon of ischemic cell death. 1. Myocardial infarct size vs dura-

tion of coronary occlusion in dogs.

Circulation

1977;

56

: 786–794.

9.

Hasche ET, Fernandes C, Freedman SB, Jeremy RW

.

Relation between

ischemia time, infarct size, and left ventricular function in humans.

Circulation

1995;

92

: 710–719.

10. Shacham Y, Steinvil A, Leshem-Rubinow E, BenAssa E, Keren G, Roth

A,

et al.

Association between time to reperfusion and echocardiography

assessed left ventricular filling pressure in patients with first ST-segment

elevation myocardial infarction undergoing primary coronary interven-

tion.

Cardiol J

2014;

21

: 357–363.

11. De Luca G, Ernst N, Zijlstra F, Van’t Hof A, Hoorntje J, Dambrink

J,

et al

. Preprocedural TIMI flow and mortality in patients with acute

myocardial infarction treated by primary angioplasty.

J Am Coll Cardiol

2004;

43

: 1363–1367.

12. Ndrepepa G, Kastrati A, Schwaiger M, Mehilli J, Markwardt C, Dibra

A,

et al.

Relationship between residual blood flow in the infarct-related

artery and scintigraphic infarct size, myocardial salvage, and functional

recovery in patients with acute myocardial infarction.

J Nucl Med

2005;

46

: 1782–1788.

13. 1Schomig A, Mehilli J, Antoniucci D, Ndrepepa G , Markwardt C,

Di Pede F, e

t al.

A beyond 12h reperfusion alternative evaluation

(BRAVE-2) trial investigators. Mechanical reperfusion in patients with

acute myocardial infarction presenting more than 12 hours from symp-

tom onset: a randomized controlled trial.

J Am Med Assoc

2005;

293

:

2865–2872.

14. Busk M, Kaltoft A, Nielsen SS, Bøttcher M, Rehling M, Thuesen L,

et al

. Infarct size and myocardial salvage after primary angioplasty in

patients presenting with symptoms for

<

12 h vs 12–72 h.

Eur Heart J

2009;

30

: 1322–1330.

15. TIMI Study Group Definitions used in TIMI trials (2008). http://www.

timi.org.

Accessed 22 January 2008.

16. Meneveau N, Seronde MF, Descotes-Genon V, Dutheil J, Chopard

R, Ecarnot F, e

t al.

Immediate versus delayed angioplasty in infarct-

related arteries with TIMI III flow and ST-segment recovery: a matched

comparison in acute myocardial infarction patients.

Clin Res Cardiol

2009;

98

: 257–264.

17. Bates ER, Hochman JS. Challenging coronary artery revascularization

paradigms.

Am Heart J

2007;

154

: 1005–1007.

18. Schomig A, Ndrepepa G, Kastrati A. Late myocardial salvage: time

to recognize its reality in the reperfusion therapy of acute myocardial

infarction.

Eur Heart J

2006;

27

: 1900–1907.

19. Sim DS, Jeong MH, Ahn Y, Kim YJ , Chae SC, Hong TJ,

et al.

Korea

acute myocardial infarction registry (KAMIR) investigators benefit

of percutaneous coronary intervention in early latecomers with acute

ST-segment elevation myocardial infarction.

Am J Cardiol

2012;

110

:

1275–1281.

20. Menon V, Pearte CA, Buller CE, Steg, PG, Forman, SA, White, HD,

et al.

Lack of benefit from percutaneous intervention of persistently

occluded infarct arteries after the acute phase of myocardial infarction

is time independent: insights from occluded artery trial.

Eur Heart J

2009;

30

: 183–191.

21. Ndrepepa G, Kastrati A, Mehilli J, Antoniucci D, Schömig A

.

Mechanical reperfusion and long-term mortality in patients with acute

myocardial infarction presenting 12 to 48 hours from onset of symp-

toms.

J Am Med Assoc

2009;

301

(5): 487–488.

22. Windecker S, Kolh P, Alfonso F, Collet JP, Cremer J, Falk V,

et al

. 2014